Membrane Localization of LRRK2 Is Associated with Increased Formation of the Highly Active LRRK2 Dimer and Changes in Its Phosphorylation

被引:166
作者
Berger, Zdenek [1 ,2 ]
Smith, Kelsey A. [1 ]
LaVoie, Matthew J. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Ctr Neurol Dis, Dept Neurol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
DISEASE-ASSOCIATED MUTATIONS; FAMILIAL PARKINSONS-DISEASE; PROTEIN-KINASE ACTIVITY; GAMMA-SECRETASE; LEUCINE-RICH-REPEAT-KINASE-2; LRRK2; GTP-BINDING; COMPLEX; DOMAIN; GENE; PRESENILIN;
D O I
10.1021/bi100157u
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Autosomal dominant mutations in leucine rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson's disease (PD). Despite the presence of multiple domains, the kinase activity of LRRK2 is thought to represent the primary function of the protein. Alterations in LRRK2 kinase activity are thought to underlie the pathogenesis of its PD-linked mutations; however, many questions regarding basic aspects of LRRK2 function remain unclear, including the cellular mechanisms of LRRK2 regulation and the importance of its unique distribution within the cell. Here, we demonstrate for the first time that the subcellular localization of wild-type LRRK2 is associated with changes in four distinct biochemical properties likely crucial for LRRK2 function. Our data demonstrate for the first time that the wild-type LRRK2 dimer possesses greater kinase activity than its more abundant monomeric counterpart. Importantly, we show that this activated form of LRRK2 is substantially enriched at the membrane of cells expressing endogenous or exogenous LRRK2, and that the membrane-associated fraction of LRRK2 likewise possesses greater kinase activity than cytosolic LRRK2. In addition, membrane-associated LRRK2 binds GTP more efficiently than cytosolic LRRK2 but demonstrates a lower degree of phosphorylation. Our observations suggest that multiple events, including altered protein protein interactions and post-translational modifications, contribute to the regulation of LRRK2 function, through modulation of membrane association and complex assembly. These Findings may have implications for the sites of LRRK2 function within the cell, the identification and localization of bona fide LRRK2 substrates, and efforts to design small molecule inhibitors of LRRK2.
引用
收藏
页码:5511 / 5523
页数:13
相关论文
共 60 条
[31]   LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc domain [J].
Korr, D ;
Toschi, L ;
Donner, P ;
Pohlenz, HD ;
Kreft, B ;
Weiss, B .
CELLULAR SIGNALLING, 2006, 18 (06) :910-920
[32]   Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation [J].
Kyriakis, JM ;
Avruch, J .
PHYSIOLOGICAL REVIEWS, 2001, 81 (02) :807-869
[33]   The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study [J].
Latourelle, Jeanne C. ;
Sun, Mei ;
Lew, Mark F. ;
Suchowersky, Oksana ;
Klein, Christine ;
Golbe, Lawrence I. ;
Mark, Margery H. ;
Growdon, John H. ;
Wooten, G. Frederick ;
Watts, Ray L. ;
Guttman, Mark ;
Racette, Brad A. ;
Perlmutter, Joel S. ;
Ahmed, Anwar ;
Shill, Holly A. ;
Singer, Carlos ;
Goldwurm, Stefano ;
Pezzoli, Gianni ;
Zini, Michela ;
Saint-Hilaire, Marie H. ;
Hendricks, Audrey E. ;
Williamson, Sally ;
Nagle, Michael W. ;
Wilk, Jemma B. ;
Massood, Tiffany ;
Huskey, Karen W. ;
Laramie, Jason M. ;
DeStefano, Anita L. ;
Baker, Kenneth B. ;
Itin, Ilia ;
Litvan, Irene ;
Nicholson, Garth ;
Corbett, Alastair ;
Nance, Martha ;
Drasby, Edward ;
Isaacson, Stuart ;
Burn, David J. ;
Chinnery, Patrick F. ;
Pramstaller, Peter P. ;
Al-hinti, Jomana ;
Moller, Anette T. ;
Ostergaard, Karen ;
Sherman, Scott J. ;
Roxburgh, Richard ;
Snow, Barry ;
Slevin, John T. ;
Cambi, Franca ;
Gusella, James F. ;
Myers, Richard H. .
BMC MEDICINE, 2008, 6 (1)
[34]   Dopamine covalently modifies and functionally inactivates parkin [J].
LaVoie, MJ ;
Ostaszewski, BL ;
Weihofen, A ;
Schlossmacher, MG ;
Selkoe, DJ .
NATURE MEDICINE, 2005, 11 (11) :1214-1221
[35]   Assembly of the γ-secretase complex involves early formation of an intermediate subcomplex of Aph-1 and nicastrin [J].
LaVoie, MJ ;
Fraering, PC ;
Ostaszewski, BL ;
Ye, WJ ;
Kimberly, WT ;
Wolfe, MS ;
Selkoe, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (39) :37213-37222
[36]   The R1441C mutation of LRRK2 disrupts GTP hydrolysis [J].
Lewis, Patrick A. ;
Greggio, Elisa ;
Beilina, Alexandra ;
Jain, Shushant ;
Baker, Acacia ;
Cookson, Mark R. .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 357 (03) :668-671
[37]   Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants [J].
Li, Xianting ;
Tan, Yin-Cai ;
Poulose, Shibu ;
Olanow, C. Warren ;
Huang, Xin-Yun ;
Yue, Zhenyu .
JOURNAL OF NEUROCHEMISTRY, 2007, 103 (01) :238-247
[38]   Leucine-Rich Repeat Kinase 2 Regulates the Progression of Neuropathology Induced by Parkinson's-Disease-Related Mutant α-synuclein [J].
Lin, Xian ;
Parisiadou, Loukia ;
Gu, Xing-Long ;
Wang, Lizhen ;
Shim, Hoon ;
Sun, Lixin ;
Xie, Chengsong ;
Long, Cai-Xia ;
Yang, Wan-Jou ;
Ding, Jinhui ;
Chen, Zsu Zsu ;
Gallant, Paul E. ;
Tao-Cheng, Jung-Hwa ;
Rudow, Gay ;
Troncoso, Juan C. ;
Liu, Zhihua ;
Li, Zheng ;
Cai, Huaibin .
NEURON, 2009, 64 (06) :807-827
[39]   Wild-type LRRK2 but not its mutant attenuates stress-induced cell death via ERK pathway [J].
Liou, Anthony K. F. ;
Leak, Rehana K. ;
Li, Lihua ;
Zigmond, Michael J. .
NEUROBIOLOGY OF DISEASE, 2008, 32 (01) :116-124
[40]   Kinetic Mechanistic Studies of Wild-Type Leucine-Rich Repeat Kinase2: Characterization of the Kinase and GTPase Activities [J].
Liu, Min ;
Dobson, Brittany ;
Glicksman, Marcie A. ;
Yue, Zhenyu ;
Stein, Ross L. .
BIOCHEMISTRY, 2010, 49 (09) :2008-2017